Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.
about
Increasing antipsychotic dose for non response in schizophreniaIncreasing antipsychotic dose versus switching antipsychotic for non response in schizophreniaNeurophysiological Changes Induced by Chronic Toxoplasma gondii InfectionPotentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Cognitive control of gaze in bipolar disorder and schizophrenia.Neural vulnerability factors that increase risk for future weight gain.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Can Stopping Nerves, Stop Cancer?Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD.Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist.Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.[Evidence-based treatment of psychosis associated with Parkinson's disease].COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine.
P2860
Q24186768-76ED2711-EDF8-449E-B4DC-925DF125E941Q24186772-76CD62FC-84C5-4B88-9415-F671A801DDDAQ33847259-337900B9-00AD-455E-93F8-170C985CED91Q34505456-41ED954F-DFD3-4331-970C-14FC31C81D8BQ34703195-F2D587A8-06A4-4441-AAC3-BBDA96DADEC3Q35182103-84C232DC-EE64-458C-939B-7345DEA1A09FQ36777473-142F21E3-C55D-4C94-92F0-B0BCFE2DC555Q38284625-E4C37A92-E37E-417D-8911-AFC823965C5EQ38796646-AAA32278-E23B-4EEB-A92B-4753D44FC87DQ40400512-0C40FE3E-7EC1-436B-8BC4-D78B9BA00D51Q48313320-16CA9BB1-8F3B-4986-BC54-C8A118E0AB35Q49949879-B8A08AC1-DFD9-4FB1-83EB-6EF18A5FF296Q53651478-CD6EDD37-7024-439D-AD7E-5F10EE5DDE9AQ53652604-F4B464E3-6FD8-4293-B619-9099C59E55CE
P2860
Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Mechanisms of action of antips ...... vity to their actions: Part I.
@en
type
label
Mechanisms of action of antips ...... vity to their actions: Part I.
@en
prefLabel
Mechanisms of action of antips ...... vity to their actions: Part I.
@en
P2860
P1476
Mechanisms of action of antips ...... vity to their actions: Part I.
@en
P2093
P2860
P304
P356
10.2174/157015909790031229
P577
2009-12-01T00:00:00Z